Cited by 596Bone health and osteoporosis researchBone health and treatmentsBone Metabolism and Diseases

The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.

Use of bone turnover markers in postmenopausal osteoporosis

Eastell, Richard, Szulc, Pawel·2017·The Lancet Diabetes & Endocrinology

Open this paper in CoChat — free account

Abstract

Bone turnover comprises two processes: the removal of old bone (resorption) and the laying down of new bone (formation). N-terminal propeptide of type I procollagen (PINP) and C-telopeptide of type I collagen (CTX-I) are markers of bone formation and resorption, respectively, that are recommended for clinical use. Bone turnover markers can be measured on several occasions in one individual with good precision. However, these markers are subject to several sources of variability, including feeding (resorption decreases) and recent fracture (all markers increase for several months). Bone turnover markers are not used for diagnosis of osteoporosis and do not improve prediction of bone loss or fracture within an individual. In untreated women, very high bone turnover marker concentrations suggest secondary causes of high bone turnover (eg, bone metastases or multiple myeloma). In people with osteoporosis, bone turnover markers might be useful to assess the response to anabolic and antiresorptive therapies, to assess compliance to therapy, or to indicate possible secondary osteoporosis. Much remains to be learnt about how bone turnover markers can be used to monitor the effect of stopping bisphosphonate therapy (eg, to identify a threshold above which restarting therapy should be considered). More studies are needed to investigate the use of bone turnover markers for assessment of the bone safety of new medications.

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(17)30184-5

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American Society for Bone and Mineral Research
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
Khan, A. A., Morrison, A. D., Hanley, D. A., Felsenberg, D., McCauley, L. K., O’Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2405 · Cited by 1,360
Self-citation
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1305224 · Cited by 1,258
Denosumab in postmenopausal women with low bone mineral density.
McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044459 · Cited by 1,228
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
for the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212
Self-citation
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
Gharib, H., Papini, E., Paschke, R., Duick, D. S., Valcavi, R., Hegedűs, L. D., Vitti, P., Gharib, H., Papini, E., Paschke, R., et al. (2010) · Endocrine Practice · doi:10.4158/10024.gl · Cited by 1,087
Molecular Mechanisms Mediating Proliferation/Differentiation Interrelationships During Progressive Development of the Osteoblast Phenotype
Stein, G. S., & Lian, J. B. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-424 · Cited by 1,058

Show all 168 references

Sorted by citations

Items 501–596 of 596

Additional file 3 of Machine learning analysis of gene expression profile reveals a novel diagnostic signature for osteoporosis
Chen, X., Liu, G., Wang, S., Zhang, H., & Xue, P. Q. (2021) · Figshare · doi:10.6084/m9.figshare.14220936
Additional file 4 of Machine learning analysis of gene expression profile reveals a novel diagnostic signature for osteoporosis
Chen, X., Liu, G., Wang, S., Zhang, H., & Xue, P. Q. (2021) · Figshare · doi:10.6084/m9.figshare.14220939
Elemental detection and mapping of rat bone matrix induced by chemoradiotherapy with confocal μ-XRFPreprint
Li, Q., Chen, H., Zhou, L., & Li, F. (2024) · Research Square · doi:10.21203/rs.3.rs-4180548/v1
Development and Validation of a Novel Nomogram Based on Systemic Immune-Inflammation Index for Predicting the Risk of Osteoporosis in Chinese Male PopulationPreprint
Zhuo, H., Zhou, Z., Chen, X., Song, Z., Shang, Q., Huang, H., Xiao, Y., Wang, X., Chen, H., Yan, X., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4261340/v1
Association of geriatric nutritional risk index with bone mineral density and osteoporosis in postmenopausal elderly women with T2DM.
Zhao, Y., Chen, C., Lv, X., Li, K., Wang, Y., Ma, D., Zan, X., Han, M., Guo, X., Fu, S., et al. (2024) · PubMed Central · doi:10.6133/apjcn.202409_33(3).0014
Indicators for Risk of Hip Fracture in Elderly Women Without OsteoporosisPreprint
Bian, Y., Zhao, J., He, S., Cao, J., Jiang, D., & Jia, W. (2024) · Research Square · doi:10.21203/rs.3.rs-4475728/v1
Artemisia annua L. extract regulates bone-fat metabolism on glucocorticoid-induced osteoporosis via regulating PGC-1α/Nrf2-mediated oxidative stressPreprint
Lai, L., Xia, T., Ding, L., Li, K., Xu, S., Jiang, Y., Fan, W., Yue, X., & Xin, H. (2024) · Research Square · doi:10.21203/rs.3.rs-4667927/v1
Association between changes in serum bone metabolism markers and bone microarchitecture changes during basic combat training – The ARMI study
Coulombe, J. C., Bozzini, B. N., Guerriere, K. I., Foulis, S. A., Reynoso, M., Walker, L. A., Staab, J. S., Bouxsein, M., Hughes, J. M., & Popp, K. L. (2024) · Bone · doi:10.1016/j.bone.2024.117241
Elemental detection and mapping of rat bone matrix induced by chemoradiotherapy with confocal micro-XRFPreprint
Li, Q., Chen, H., Zhai, Y., & Li, F. (2024) · Research Square · doi:10.21203/rs.3.rs-4842366/v1
Turning the Tables: Estradiol as a Protective Factor in Breast Cancer Risk - Findings from a NHANES-Based Study on Lead and Cadmium ExposurePreprint
Lu, Y., Xu, H., Yang, J., Zhang, Q., Kong, W., Yang, D., Ma, L., Zhang, S., Yan, P., & Yang, K. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4962461
Mechanism of NPC1L1 mediated 27-hydroxycholesterol metabolisms in the occurrence and development of osteoporosisPreprint
Li, B., Lv, Z., Chen, B., Zhang, T., Yu, Y., Sun, S., Huang, H., Zhou, L., & Wang, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.30.615783
WITHDRAWN: Nrf2 mediates the antioxidant and anti-osteoporotic effects of sinigrin.
Zhen, M., Lu, Q., & Wang, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39528
Retracted
Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate
Suwan, A., Tanavalee, C., Panyakhamlerd, K., Ngarmukos, S., Chavaengkiat, S., Tanavalee, A., Amarase, C., & Bumphenkiatikul, T. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03404-5
Lumbar Magnetic Resonance Imaging Shows Sex-Specific Alterations During Musculoskeletal Aging—A Radio-Anatomic Investigation Involving 202 Individuals
Balling, H., Holzapfel, B. M., Böcker, W., Simon, D., Reidler, P., & Arnholdt, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237233
A Randomized Controlled Pilot Study on the Short-Term Impact of Meal Frequency on Bone Remodeling in Healthy Adults
Haddad, A. J., Albardan, L., Jahrami, H., Amawi, A. T., & Ghazzawi, H. (2024) · Palestinian medical and pharmaceutical journal/Palestinian medical & pharmaceutical journal · doi:10.59049/2790-0231.1277
Characteristic and Prognostic Value of Serum Bone Turnover Markers in Pregnant Women With Pre‐Eclampsia: A Prospective Cohort Study
Fan, Y., Huang, X., Tang, Y., Zhang, Y., Li, Q., & Jiang, Y. (2024) · International Journal of Clinical Practice · doi:10.1155/ijcp/8816587
Study of bone turnover biomarkers behavior during the first year post-kidney transplantation
Lloret, M. J., Canal, C., Montañés, R., Gregorio, S. D., de Arizón, L. F., Tinoco, A., Láiz, A. M., Montolio, D., Facundo, C., Guirado, L., et al. (2025) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.20960/revosteoporosmetabminer.00063
Variation Patterns and Correlation Between BTMs and Microparameters of Trabecular Bone and Macro－mechanical Strength of Lumbar VertebraePreprint
Jia, Y., Xia, N., Zhao, J., Xu, W., Wang, W., Yu, H., Zhang, Y., & Liu, D. (2025) · Research Square · doi:10.21203/rs.3.rs-6161804/v1
Serum alkaline phosphatase/creatinine ratio serving as a screening tool for low lumbar bone mineral density in patients with degenerative lumbar scoliosis
Cai, Z., Sun, X., Shi, B., Feng, Z., Li, S., Zhu, Z., Qiu, Y., & Shi, B. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-05819-8
Bone turnover markers in osteoporosis - a common position on their use by the Society for Metabolic Skeletal Diseases (SMOS) of the Czech Medical Association JEP and the Czech Society of Clinical Biochemistry (CSCB)
Pikner, R., Palička, V., da Rosa, J. C. B., Zikán, V., Švagera, Z., Racek, J., Friedecky, B., Kratochvíla, J., & Zima, T. (2020) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2020.014
Degradable calcium phosphate-coated porous zinc scaffold combined with platelet-rich plasma implantation for rabbit radius defect
Wang, X., He, W., Hu, S., Bai, R., Sun, C., Hao, T., Xue, F., Pei, Z., Wei, H., Wu, Y., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-02676-3
Are there associations between bone turnover and hip geometry in the general population?
Fischer, C. S., Ittermann, T., Kalmbach, S., Herbst, M., Histing, T., Lange, J., & Hannemann, A. (2025) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2025.05.007
Mechanisms of Anemarrhenae Rhizoma in Treating Osteoporosis in Rats: An Integrated Metabolomics and Transcriptomics Analysis
Wen, Y., Huang, Z., Hong, X., Jiang, Q., Han, L., Wang, Q., Wang, J., Shang, X., Wu, Z., & Huang, T. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.10069
Revisão sobre fraturas osteoporóticas: Ocorrência, prevenção e consequências
Elias, N., Ribeiro, J. E. G., Campinho, L. A., Reis, C., Elias, L. A. M. S., & Labronici, P. J. (2025) · Revista Brasileira de Ortopedia · doi:10.1055/s-0045-1809515
Decreased Bone Turnover Markers in Children with Cerebral PalsyPreprint
Pedersen, M. L., Ohlendorff, J. S., Gerds, T. A., Zehran, B., Debes, N. M., Hoei‐Hansen, C. E., Jørgensen, N. R., & Johannesen, J. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5351165
Biochemical Monitoring in Oral and Maxillofacial Surgery: Feasibility and Application Perspectives in African Context
Daniel, N. S., & Moor, V. J. A. (2025) · Advances in Biochemistry · doi:10.11648/j.ab.20251303.13
Comparing the Effects of Dairy and Soybean on Bone Health in Women: A Food- and Component-Level Network Meta-Analysis
Li, Y., Wang, L., Zhou, S., Guan, Y., Liu, Y., Zhu, R., Chen, H., Guo, J., Li, K., Bao, X., et al. (2025) · Nutrients · doi:10.3390/nu17172833
Modelling of multisegmental osteoporotic vertebral compression fracture using machine learning to analyse and predict risk factors.Preprint
Zhu, X., Zhang, L., Zhang, Y., Si, W., Liu, D., & Song, A. (2025) · Research Square · doi:10.21203/rs.3.rs-7295247/v1
Noninvasive Terahertz Therapy Promoted Bone Regeneration via Localized Angiogenesis in a Pre-Clinical Tibial Defect Model
Liu, L.-Z., Geng, S., Jiang, Y., Fu, J., Shu, Z., Liu, H., Jia, W., & Huang, G. (2025) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1177/15578550251363058
Perioperative Denosumab Versus Bisphosphonates for MIDLF Surgery in Patients With Osteopenia: A Short-Term Prospective Cohort Study
Changsheng, H., Yue, L., Wang, S., & Sun, H. (2025) · Global Spine Journal · doi:10.1177/21925682251372500
Effectiveness of traditional Chinese exercises in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis
Yu, J., Chen, S., Chen, Y., Shi, Q., Zhou, K.-D., & Wang, P.-J. (2025) · Medicine · doi:10.1097/md.0000000000044407 · Cited by 1
OSTEOPOROSIS IN MEN – A CONTEMPORARY PERSPECTIVE ON DIAGNOSIS, TREATMENT AND FRACTURE PREVENTION STRATEGIES
Mokrzycka, A., Żuczek, A., Dyndał, K., Broda, M., Żuczek, O., Urbańska, K., Szczap, I., Hawryluk, A., & Marzec, K. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3893
Moisture‐Tolerant Polyurethane‐Based Bone Cement Containing Enoxacin for the Sex‐Specific Repair of Osteoporotic Defects
Zhang, J., Lei, X., Tang, J., Zhao, Q. F., Li, L., Feng, J., Li, Y., & Zuo, Y. (2025) · Journal of Applied Polymer Science · doi:10.1002/app.58080
Effects of Nigella sativa on bone turnover markers in postmenopausal women: a comprehensive review
Zargar, S., Bajestani, F. S., Sahebanmaleki, M., Nattagh‐Eshtivani, E., & Rashidmayvan, M. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100904
Effect of Depletion of Developmentally Regulated GTP Binding Protein on Osteoblastic Differentiation and Bone Microarchitecture
Jin, Y., Cho, M., & Lee, J. H. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70895
Pharmacological vs non-pharmacological treatment in the management of Relative Energy Deficiency in Sport (RED-S): A systematic review and meta-analysisPreprint
Wood, A., & Soundy, A. (2025) · medRxiv · doi:10.1101/2025.07.18.25331767
Development and validation of a cross-species C-telopeptide ELISA for bone resorption: application in ovariectomized mice and Pacific Bluefin Tuna
Tanaka, T., Moriyama, T., & Kawamura, Y. (2025) · Journal of Veterinary Medical Science · doi:10.1292/jvms.25-0376
Genomic structural equation modeling uncovers novel risk loci for bone metabolic disorders: cross-tissue genetic mechanisms and bone-brain axis regulation
Zhou, Y., Huang, J., Xu, L., Zhang, F., Bai, C., Fan, F., Wang, Y., Fang, B., Wang, T., Mu, X., et al. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-09291-7 · Cited by 1
A threshold of β-CTX (0.3 ng/mL) with low estradiol identifies high-risk perimenopausal women for bone loss: a cross-sectional study
Feng, X., Xiao, W., & Zhang, R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1709858
Development of a Rifapentine-Loaded Alendronate-Conjugated PLGA-PEG Nanosystem: A Novel Bone-Targeted Strategy for Osteoarticular Tuberculosis Treatment with Enhanced Drug Delivery and Bone Regeneration
Wang, Z., Hong, W., Qiu, X., Zhao, B., & Yang, Z. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s478893
Additional file 1 of Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis
Hong, P., Liu, R., Rai, S., Liu, J., Zhou, Y., Zheng, Y., & Li, J. (2024) · Figshare · doi:10.6084/m9.figshare.26569171
Additional file 1 of Analyzing the factors associated with efficacy among teriparatide treatment in postmenopausal women with osteoporosis
Kong, M., Gao, C., Luan, X., Fan, C., Hao, M., Jin, C., Zhao, J., Li, H., Zhao, J., Luan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26676566
Additional file 1 of Ångstrom-scale gold particles loaded with alendronate via alpha-lipoic acid alleviate bone loss in osteoporotic mice
Gao, W., Li, J. J., Shi, J., Lan, H., Guo, Y., & Fu, D. (2024) · Figshare · doi:10.6084/m9.figshare.26714308
Additional file 2 of Machine learning analysis of gene expression profile reveals a novel diagnostic signature for osteoporosis
Chen, X., Liu, G., Wang, S., Zhang, H., & Xue, P. (2021) · Figshare · doi:10.6084/m9.figshare.14220933
Additional file 1 of Young osteocyte-derived extracellular vesicles facilitate osteogenesis by transferring tropomyosin-1
Wang, Z.-X., Lin, X., Cao, J., Liu, Y.-W., Luo, Z.-W., Rao, S.-S., Wang, Q., Wang, Y.-Y., Chen, C.-Y., Zhu, G.-Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25698287
Additional file 1 of Machine learning analysis of gene expression profile reveals a novel diagnostic signature for osteoporosis
Chen, X., Liu, G., Wang, S., Zhang, H., & Xue, P. (2021) · Figshare · doi:10.6084/m9.figshare.14220930
Establishment of Biological Reference Intervals for Type I Collagen Cross-Linked N-Telopeptide (NTx) in Adults in the Qingdao Region
崔, 佳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123617
Development and validation of a method for quantitation of CTx-1 for the assessment of biosimilarity of FKS518, a denosumab biosimilar
de Souza, A. L. S., Buccarello, A. L., Berthet, A., Ullmann, M., & Petit-Frère, C. (2025) · Bioanalysis · doi:10.1080/17576180.2025.2607081
Study on the correlation between serum bone turnover markers and osteoporotic fractures in elderly men
Cheng, P., & Zhang, M. (2025) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2025.11.245
Subchondral Insufficiency Fracture of the Humeral Head: A Rare Case in a Young Person
Murayama, H., & Mizuki, Y. (2026) · Cureus · doi:10.7759/cureus.101654
Clinical practice guidelines for the diagnosis and treatment of osteoporosis secondary to ankylosing spondylitis
Li, Y., Wang, L., Wang, H., Wang, H., Wu, H., 应奇峰, Zhao, D., He, L., Zhang, X., Zhu, J., et al. (2026) · Rheumatology & autoimmunity · doi:10.1002/rai2.70036
Protein compound macrophage migration inhibitory factor for diagnosing postmenopausal osteoporosis
Wang, C., Huang, F., Lai, H., Cai, E., Ma, D., Bai, Y., He, D., & Chen, Z. (2026) · Frontiers in Chemistry · doi:10.3389/fchem.2026.1780639
The METTL14/YTHDF3 axis regulates EPSTI1-mediated osteogenic differentiation of human bone marrow mesenchymal stem cells
Zheng, C., Ding, L., Xu, Y., Yuan, C., Jiang, B., Chen, T., & Wang, Y. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103386
Association of central adiposity and metabolic markers with osteopenia and osteoporosis in Chinese adults: a QCT-based cross-sectional study
Wang, L., Yu, P., Chen, Y., Chen, M., Deng, J., & Yu, L. (2026) · Scientific Reports · doi:10.1038/s41598-026-37749-8 · Cited by 1
Investigation of the Possible Mechanisms behind Cyclolinopeptides’ Anti-Osteoporotic Effects Using Network Pharmacology Analysis
Oconnor, P. A., Murphy, D. T., & Kelly, S. W. (2021) · Journal of Medical Sciences and Interdisciplinary Research · doi:10.51847/yzp5ubeems
TSH suppression attenuates the early efficacy of zoledronic acid in osteoporosis
Liu, Y., Zhang, Y., Li, M., Qian, Y., Zhang, Z., Jiang, Z., & Qu, W. (2026) · Archives of Osteoporosis · doi:10.1007/s11657-026-01672-2
Plasma metabolomic profiles and risk of hip fracture among US individuals: a nested case–control and prospective cohort study
Wu, Z., Sun, Q., Liu, B., Curhan, G. C., Ávila-Pacheco, J., Clish, C. B., Zeleznik, O. A., & Paik, J. M. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106188
Can P1NP Levels Influence Management Planning for Patients With a Fragility Hip Fracture Receiving Anti-resorptive Medications?
Kraidi, M., Wilkinson, I. D., & Bandyopadhyay, S. (2026) · Cureus · doi:10.7759/cureus.104983
Follistatin-like protein 1 (FSTL1) modulates bone remodeling and attenuates bone loss in a mouse model of postmenopausal osteoporosis
Yuan, H., Chen, B.-R., Han, F.-X., Huang, K., Jia, Z.-H., Dong, Y.-Y., & Bo, L. (2026) · JBMR Plus · doi:10.1093/jbmrpl/ziag037
Chronobiology and clock genes in bone and mineral metabolism
Egstrand, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00019-0
Bone Turnover Biomarkers and Hip Fracture Patterns in Older Adults: A Retrospective Cohort Study
Mifsut, D., Baños-Gómez, J., Hernández-Balada, J., & Hurtado-Oliver, V. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15093288
Effects of a 1-year calcium-enriched permeate supplement on bone health in postmenopausal females: The RENEW randomized controlled intervention trial
Tetens, I., Kisi, S. B., Parlesak, A., Rasmussen, S. I. I., Cramon, M. Ø., Petersen, C. F., Lemay, D. G., Nielsen, D. S., Bertram, H. C., Andersen, H. H., et al. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101339 · Cited by 1
Reduced bone turnover in non-obese women with polycystic ovary syndrome: a cross-sectional study on procollagen-1 N-terminal peptide and beta-C terminal telopeptide
Kırlangıç, M. M., Şahin, E., Şahin, M. E., Yalman, M. V., Akdemir, E., Birol, P., & Kütük, S. (2026) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20251481
Zuo Gui pill alleviates M1 macrophage polarization in type 2 diabetic osteoporosis through the Nrf2/HO-1/XCT/GPX4 pathway
Zhao, Y., Xiu-zhi, F., Cao, W.-Q., Chen, Y.-R., Yang, Y., Liu, J.-C., Xu, A., Ren, Y.-L., & Wang, Z.-M. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i5.117635
An explainable predictive machine learning model of osteopenia for perimenopausal women based on clinical data: a retrospective single-center study
Zhuo, X., Zeng, H., Chen, H., 王运林, Feng, Z., & Liang, Q. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1817729
Sarcopenia Risk, Bone Turnover and Metabolic Health Indices Among Community-Dwelling Older Adults in Ghana: An Observational Study
Kpabitey, I. L., Ofori, E. K., Nyarko, E., Ateko, R. O., Amponsah, S. K., Issahaku, A., Assan, N. A., Amugi, C. N., Asare-Anane, H., & Yawson, A. (2026) · Sage open aging · doi:10.1177/30495334261456207
Fracture Risk Assessment in People with Osteoporosis/Osteopenia with Urine NTx (Urinary N-Terminal Telopeptides): An Exploratory Retrospective Study
Emad, Y., Gheita, T. A., Ragab, Y., Khairy, N. A., Kassem, I. A., Alhusseiny, K., Elnaggar, A., Omar, S., Harraz, E. M., Hammam, N., et al. (2026) · Rheumato · doi:10.3390/rheumato6030014
18 F-NaF PET/CT Versus 18 F-FDG PET/CT for Baseline Mapping in Ollier Disease: A Pediatric Case
Karangutkar, S., Haroon, A., & Elramadi, A. A. A. (2026) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.126.272370
Gene III® L-Ergothioneine, alone or combined with vitamin K2, vitamin D3 and magnesium L-threonate, attenuates bone turnover, inflammatory and oxidative disturbances in ovariectomized micePreprint
Liu, W. T., Tang, Y. T., Ding, W., Cao, J., Guo, C., & Xiao, G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.23.734114
Dynamics of Bone Turnover Markers Across the Menopausal Transition: A Retrospective AnalysisPreprint
Duan, S., Li, W., Long, Y., Li, M., & Qiu, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-9776620/v1
The impact of patient adherence on the efficacy of osteoporosis pharmacotherapy
Kolesárová, M., Pavlíková, Ľ., Marcinčáková, D., Mačeková, Z., Kolesár, D., Seman, L., & KYSELOVIC, J. (2026) · Clinical Osteology · doi:10.36290/clo.2026.015
Osteochondral Unit Dysfunction in Osteoarthritis: Genetic, Epigenetic, and Hormonal Mechanisms
Menaka, M., Bindusha, A., & Reddy, B. M. (2026) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3511
Combination and sequential therapy for postmenopausal osteoporosis: recent advances and clinical practice
Liu, J., Hu, Y., Yao, Z., & Wang, H. (2026) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-026-00812-4
A bone-homing DNA tetrahedral framework nucleic acids nanodevice orchestrates osteogenic regeneration to rescue postmenopausal osteoporosis
Li, Q., Zhou, F., Zeng, S., Gao, Y., Shen, Q., Wu, Y., Ma, C., Lin, Y., Xiao, J., & Huang, K. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.179350
Bone-targeted delivery of VEGF/BMP2 plasmids using GLG1-modified PLGA nanoparticles for osteoporosis therapy
Zhang, C., Yu, K., Hong, R., Yao, C., Sun, J., Chen, C., Zhang, B., Zhang, Z., & Zhang, Y. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127240
Association of rs3736228 polymorphism in LRP5 gene with bone fracture and osteoporosis: a systematic review and updated meta-analysis
Zhang, C., Liu, W., Wang, Y., & Peng, Y. (2026) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-026-10270-9
Incidence of and Risk Factors for Pelvic Insufficiency Fracture in Patients With Cervical or Endometrial Cancer Treated With Intensity Modulated Radiation Therapy: A Single-Center, Prospective, Phase II Clinical Trial
Huang, Y., Mao, D., Chen, H., Li, J., Liu, Y., Yu, Z., Wang, J., Zhou, S., Zhong, Q., Wei, J., et al. (2026) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2026.07.031
Bone Turnover Markers, DXA and Mineral Metabolism in Long-Term Kidney Transplant Recipients: A Cross-Sectional Comparative Study
Akad, N., Bilhă, Ş., Dodi, G., Bilha, I.-M., Brǎnişteanu, D. D. D., Florescu, A., Akad, F., Hogas, M. M., Voroneanu, L. E., Hogas, S. M., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15155974
SHBG and APOA1 as serum biomarkers for low bone mineral density in Mexican postmenopausal women: a random forest-based analysis
Aparicio‐Bautista, D. I., Becerra‐Cervera, A., Rivera‐Paredez, B., Jiménez-Ortega, R. F., López-Pérez, T. V., Salmerón, J., Reyes‐Grajeda, J. P., Hidalgo‐Bravo, A., & Velázquez‐Cruz, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1824756
Estrobolome in the Gut–Vagina Axis: A Microbial Endocrinology Perspective
Agoni, L., Martinelli, C. V., Candiani, M., & Seta, F. D. (2026) · Reproductive Medicine · doi:10.3390/reprodmed7030040
Clinical value of hsa_circ_0003254 in postmenopausal osteoporosis and its role in the progression of osteoporosis
Chen, Z., Tan, R., Dai, Y., Wen, Y., Zhong, C., Lin, D., & Chen, W. (2026) · Gynecological Endocrinology · doi:10.1080/09513590.2026.2677988
Clinical and Laboratory Predictors of Bone Mineral Density Trajectories and Osteoporosis Progression: A Retrospective Longitudinal Cohort Study
Jambi, L., & Kabrah, S. M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15176581
The FGF23/α-Klotho Axis in Postmenopausal Osteoporosis: Associations with Bone Mineral Density and Diagnostic Discrimination
Karalök, M. H., Mısırlıoglu, N. F., Akın, O. D., & Uzun, H. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15176716
Association Between Chronic Bronchitis and Osteoporosis Among US Adults: Evidence From NHANES 1999–2010
Bi, J., Wang, R., Zhang, T., Chen, W., & Pan, X. (2026) · International Journal of Clinical Practice · doi:10.1155/ijcp/5085066
Taiwan joint consensus on the management of osteoporosis in patients with diabetes
Hwang, J., Chen, J., Tu, S., Wu, C., Wang, C., Han, D., Lee, C., Ouyang, C., Chen, S., Chen, C., et al. (2026) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2026.08.051
Combined baseline P1NP and TRAcP5b classification predicts differential bone mineral density response to romosozumab: A retrospective cohort study of 287 postmenopausal women
NAKANO, R., Ichisawa, A., Saruta, K., Kogawa, M., & Fukuda, A. (2026) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2026.101747
Parathyroid hormone suppression and calcium homeostasis shift in type 2 diabetes with osteoporosis: a propensity score-matched cross-sectional study
Huang, X., Zheng, J., Wang, Y., & Chen, H. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02549-8
Preclinical effects of naringin on bone outcomes in animal models of osteoporosis: a systematic review and meta-analysis
Tan, C., Zhou, X., Xie, Y., & Zhi, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1945663
Novel bioactive compounds in the treatment of osteoporosis: chemistry-driven discovery from preclinical validation to clinical translation
Fan, H., & Jin, S. (2026) · Frontiers in Chemistry · doi:10.3389/fchem.2026.1917991
Correlation of Mandibular Cortical Index with Bone Mineral Density and Serum Alkaline Phosphatase in Screening Postmenopausal Osteoporosis: A Diagnostic Evaluation
Aggarwal, A., Alam, K., & Goyal, R. (2026) · Journal of Indian Academy of Oral Medicine and Radiology · doi:10.4103/jiaomr.jiaomr_202_26
Antibody-Mimicking Nanocluster Ameliorates Osteoporosis in Preclinical Model
Yuan, Q., Li, Q.-Z., Zhang, Z., Xia, D., Dang, H., Wang, L., Niu, W., Chen, Z., Gao, L., Zhao, L., et al. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.6c00201
Schiff-base cross-linked pullulan-chondroitin sulfate hydrogel incorporating raloxifene-poly(2-methyl-2-oxazoline) micelles for localized therapy of postmenopausal osteoarthritis
Mourya, A., Singh, H., Arya, S., Shaikh, A. S., Bojja, B., Devangan, P., Bazaz, M. R., Dandekar, M. P., Kaki, V. R., Guru, S. K., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154794
Bone health in diabetes mellitus
Hoffmanová, P., Galuška, D., Kaňková, K., & Goldbergová, M. P. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10091-0
Bone health in myelodysplastic neoplasms: results from the prospective longitudinal BoHemE study
Weidner, H., Tsourdi, E. A., Platzbecker, A. S., Rauner, M., Baschant, U., Ledesma-Colunga, M. G., Basiak, K., Sockel, K., Balaian, E., Winter, S., et al. (2026) · Leukemia · doi:10.1038/s41375-026-03125-8
The role of biomarkers in the management of osteoporosis
Tskhakaia, I., & Saag, K. G. (2026) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2026.102206
BindingDB Entry 50019169: Discovery of Spiro[pyrrolidine-3,3'-oxindole] LXRβ Agonists for the Treatment of Osteoporosis.
BindingDB (2024) · UC San Diego · doi:10.7270/q29g5s4f

Authors: Eastell, R., & Szulc, P.
Affiliations: University of Sheffield (GB)
Corresponding author: Eastell, Richard
ORCID: Eastell, Richard
Venue: The Lancet Diabetes & Endocrinology
Publisher: Elsevier BV
Published: 2017-11
Volume: 5
Issue: 11
Pages: 908-923
ISSN: 2213-8587 (ISSN-L)
DOI: 10.1016/s2213-8587(17)30184-5
OpenAlex: W2733907025
Cited by: 594
References: 168
Citations by year: 2026: 62 · 2025: 94 · 2024: 89 · 2023: 82 · 2022: 92 · 2021: 75 · 2020: 47 · 2019: 32 · 2018: 18 · 2017: 3
FWCI: 4.97
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Diabetes & Endocrinology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute for Health and Care Research (NF-SI-0513-10073)
Medical Research Council (MR/K006312/1, MR/P020941/1)
Topics: Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Health Sciences › Medicine › Oncology › Bone health and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords: bone turnover markers, postmenopausal osteoporosis, bone resorption, bone formation, P1NP, C-terminal telopeptide of type I collagen, secondary osteoporosis, fracture risk prediction
MeSH terms: Diphosphonates, Humans, Biomarkers, Bone Density, Osteoporosis, Postmenopausal, Bone Remodeling, Fracture Healing, Bone Density Conservation Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Use of bone turnover markers in postmenopausal osteoporosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks